<DOC>
	<DOCNO>NCT00000748</DOCNO>
	<brief_summary>To compare safety efficacy two dosage regimen ( daily thrice-weekly ) sulfamethoxazole/trimethoprim ( SMX/TMP ; TMS ) prevention Pneumocystis carinii pneumonia ( PCP ) high-risk HIV-infected patient . Previous test show SMX/TMP give daily effective prevent recurrence PCP may effective prevent PCP patient never develop . Because SMX/TMP cause side effect , study attempt determine safest effective dose combination .</brief_summary>
	<brief_title>A Randomized , Comparative , Prospective Study Daily Trimethoprim / Sulfamethoxazole ( TMS ) Thrice-Weekly TMS Prophylaxis Against PCP HIV-Infected Patients</brief_title>
	<detailed_description>Previous test show SMX/TMP give daily effective prevent recurrence PCP may effective prevent PCP patient never develop . Because SMX/TMP cause side effect , study attempt determine safest effective dose combination . Patients receive SMX/TMP orally daily thrice-weekly basis . Patients clinically evaluate every 4 month . Patients daily SMX/TMP develop drug-related toxicity may switch thrice-weekly SMX/TMP . Duration follow-up 12 month .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4 count &lt; = 200 cells/mm3 OR history prior PCP . No active pneumocystosis . Patients guardian must sign informed consent . Pregnant patient eligible clinician 's discretion . Patients meet required laboratory value may eligible discretion clinician . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Known treatmentlimiting reaction sulfonamide trimethoprim . Concurrent Medication : Excluded : Other PCP prophylaxis medication antiPCP activity .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Sulfamethoxazole-Trimethoprim</keyword>
</DOC>